Skip to main content
  • Home
  •  AF Stroke Prevention – Applying New Guidance in the Real World

AF Stroke Prevention – Applying New Guidance in the Real World

Topic:
  • Heart Rhythm

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

AF Stroke Prevention – Applying New Guidance in the Real World
No ratings

Overview

First presented at ESC 2024, this on-demand course sees Prof Gregory Lip (University of Liverpool, UK) lead a faculty comprising Prof Elena Arbelo (University of Barcelona, ES), Prof Thorsten Hanke (Asklepios Klinikum Harburg, DE) and Prof Richard Whitlock (McMaster University, CA) review the application of the latest AF guidance in a clinical setting.

 

This case-based programme explores the considerations of risks in the assessment of treatment strategies, the impact of the guidelines on decision making and the evidence supporting non-pharmacological stroke prevention.

Support Statement

This course is supported by an unrestricted educational grant from AtriCure, Inc.

Disclosure

In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the course are declared.  

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the 'Faculty' section if applicable.

 

The session, ‘AF Stroke Prevention – Applying New Guidance in the Real World’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits.

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. 

Instruction to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must: 

  • Read the course outline information supplied. Users must read and study the activity in its entirety before completing the post-test questions. 
  • Your results will be automatically saved and if a pass score is achieved, you may be eligible to claim credit for the activity and receive a certificate of completion. 

Target Audience

  • Electrophysiologists
  • General Cardiologists
  • HCPs involved in stroke management and prevention

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Recall the risk of ischaemic stroke in AF patients
  • Compare therapeutic efficacy and risk between left atrial appendage closure and oral anticoagulation in atrial fibrillation
  • Review European guideline updates on the use of left atrial appendage closure in atrial fibrillation
  • Summarise the clinical evidence behind non-pharmacological approaches to stroke prevention in atrial fibrillation
Register now Log in

Module

Title

Duration

Speakers

1. Introduction and Patient Case 6m Gregory Lip Elena Arbelo
2. Faculty Discussion on Balancing Risk 8m Gregory Lip Elena Arbelo Thorsten Hanke Richard Whitlock
3. AF Guideline Updates 10m Thorsten Hanke
4. Evidence for Non-pharmacological Stroke Prevention 9m Richard Whitlock
5. Patient Case Revisited, Faculty Discussion and Close 8m Gregory Lip Elena Arbelo Thorsten Hanke Richard Whitlock
1..

Introduction and Patient Case

Duration: 6m

Speakers: Gregory Lip Elena Arbelo

2..

Faculty Discussion on Balancing Risk

Duration: 8m

Speakers: Gregory Lip Elena Arbelo Thorsten Hanke Richard Whitlock

3..

AF Guideline Updates

Duration: 10m

Speakers: Thorsten Hanke

4..

Evidence for Non-pharmacological Stroke Prevention

Duration: 9m

Speakers: Richard Whitlock

5..

Patient Case Revisited, Faculty Discussion and Close

Duration: 8m

Speakers: Gregory Lip Elena Arbelo Thorsten Hanke Richard Whitlock

Course Director

Gregory Lip

Prof Lip is Price-Evans Chair of Cardiovascular Medicine at the University of Liverpool, UK. He is also director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool and Liverpool Heart & Chest Hospital.

View full profile

Speaker

Elena Arbelo

Hospital Clínic de Barcelona, Barcelona, ES

Prof Elena Arbelo is a Cardiac Electrophysiologist at Hospital Clínic of Barcelona, Barcelona, Spain, where she serves as Coordinator of the Cardiac Genetic Diseases and Sudden Arrhythmic Death Unit.

View full profile

Speaker

Thorsten Hanke

Thorsten Hanke

Thorsten Hanke is Associate Director of the Cardiac Surgery Clinic at the Asklepios Clinic Hamburg-Harburg, Germany. He is specialised in treating atrial fibrillation surgically and inaugurated a surgical stand-alone LAA treatment program at the Cardiac Surgery Clinic in Harburg in 2016.

View full profile

Speaker

Richard Whitlock

Richard Whitlock

Richard Whitlock is a Professor of Surgery at McMaster University and a practising cardiac surgeon at Hamilton Health Sciences, Canada. Previously, he held a full-time research appointment at the Population Health Research Institute.

View full profile
1.00 EBAC

AF Stroke Prevention: Applying New Guidance in the Real World has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of effective education time. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Related Courses

Advanced Approaches to Combined Epicardial and Endocardial Strategies – From New Consensus to Practice
  • 1.00 EBAC

Learning objectives

  • Identify patient populations who may benefit from hybrid ablation
  • Summarise the existing rationale and evidence for hybrid ablation beyond atrial fibrillation
  • Understand how to integrate left atrial appendage exclusion in atrial ablation approaches
  • Examine key aspects of new consensus recommendations for hybrid ablation
See more
Hybrid Ablation – AF and Beyond
  • 1.00 EBAC

Learning objectives

  • Identify arrhythmias other than atrial fibrillation that may benefit from hybrid ablation
  • Summarise the existing evidence base for hybrid ablation in IST, POTS and Brugada Syndrome
  • Identify patients who may benefit from a hybrid ablation approach
  • Recall existing RCT and real-world evidence supporting the use of hybrid ablation in AF
See more